Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

DR REDDYS

  • FDA Approval
  • Oct. 31, 2024, 14:51 UTC
  • 64
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Oct. 31, 2024, 14:24 UTC
  • 63
  • 0 comments

FDA approve DOLUTEGRAVIR;LAMIVUDINE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • Oct. 31, 2024, 14:17 UTC
  • 54
  • 0 comments

FDA approve IVACAFTOR

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Oct. 31, 2024, 14:05 UTC
  • 53
  • 0 comments

FDA approve EPINEPHRINE

Comment Full text

INDOCO

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 45
  • 0 comments

FDA approve VARENICLINE TARTRATE

Comment Full text

NEXUS

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 53
  • 0 comments

FDA approve CYCLOPHOSPHAMIDE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 44
  • 0 comments

FDA approve LIDOCAINE HYDROCHLORIDE

Comment Full text

STERISCIENCE

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 37
  • 0 comments

FDA approve THIAMINE HYDROCHLORIDE

Comment Full text

SAGENT PHARMS

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 56
  • 0 comments

FDA approve HALOPERIDOL LACTATE

Comment Full text

KINDOS

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 53
  • 0 comments

FDA approve DOXYCYCLINE HYCLATE

Comment Full text
  • Previous
  • 323
  • 324
  • 325
  • 326
  • 327
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3373)
  • SEC News(216327)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137427)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin